A Saltzer Health urgent care clinic in Nampa is now offering COVID-19 monoclonal antibody treatment by appointment with a provider referral.
Monoclonal antibody (mAb) treatment has been shown to significantly reduce hospitalization and death from COVID-19 if administered within 10 days of symptom onset to those who are considered at high risk for developing severe illness.
The treatment is available by appointment only seven days a week at the North Nampa clinic, 9850 W. St. Luke’s Drive. Patients must be referred by a health care provider. The treatment is given as an IV infusion over 20 minutes, followed by a 1-hour observation period.
Monoclonal antibody treatment is recommended for people age 12 years who are at risk of progressing to severe disease or hospitalization due to COVID-19. Risk factors may include age (64 years or older), obesity; pregnancy; chronic kidney disease; diabetes; chronic lung disease; immunosuppressive disease; cardiovascular disease.
Treatments are given at no cost to the patient, and health insurance isn’t required.
“While this treatment is not meant to replace vaccinations to prevent COVID, it has been proven as an effective treatment for COVID-infected patients to decrease hospitalization and death,” said Dr. John Kaiser, Saltzer Health chief medical officer.
The treatment is authorized for emergency use by the Food and Drug Administration. Clinical trials showed monoclonal antibodies could reduce hospitalizations and deaths by 70%.
“Monoclonal antibody treatment will allow us to help people avoid hospitalization and reduce the disease burden in our community,” he said. “Saltzer Health is pleased to be able to minimize the impact of COVID on vulnerable patients and their families.”
The Saltzer Health mAb treatment center is operated under a contract with the Idaho Department of Health & Welfare.
A provider referral is required to receive treatment. Those without a primary care provider are urged to contact Saltzer Health at 208.463.3000